Gastric adenomas and their management in familial adenomatous polyposis

Abstract

Background Patients with familial adenomatous polyposis (FAP) are at increased risk of developing gastric adenomas. There is limited understanding of their clinical course and no consensus on management. We reviewed the management of gastric adenomas in patients with FAP from two centers.

Methods Patients with FAP and histologically confirmed gastric adenomas were identified between 1997 and 2018. Patient demographics, adenoma characteristics, and management/surveillance outcomes were collected.

Results Of 726 patients with FAP, 104 (14 %; 49 female) were diagnosed with gastric adenomas at a median age of 47 years (range 19 – 80). The median size of gastric adenomas was 6 mm (range 1.5 – 50); 64 (62 %) patients had adenomas located distally to the incisura. Five patients (5 %) had gastric adenomas demonstrating high-grade dysplasia (HGD) on initial diagnosis, distributed equally within the stomach. The risk of HGD was associated with adenoma size (P = 0.04). Of adenomas > 20 mm, 33 % contained HGD. Two patients had gastric cancer at initial gastric adenoma diagnosis. A total of 63 patients (61 %) underwent endoscopic therapy for gastric adenomas. Complications occurred in three patients (5 %) and two (3 %) had recurrence, all following piecemeal resection of large (30 – 50 mm) lesions. Three patients were diagnosed with gastric cancer at median follow-up of 66 months (range 66 – 115) after initial diagnosis.

Conclusions We observed gastric adenomas in 14 % of patients with FAP. Of these, 5 % contained HGD; risk of HGD correlated with adenoma size. Endoscopic resection was feasible, with few complications and low recurrence rates, but did not completely eliminate the cancer risk.

Publication History

Received: 21 February 2020

Accepted: 17 September 2020

Accepted Manuscript online:
17 September 2020

Article published online:
05 November 2020

• References

• 1 Kinzler K, Nilbert M, Su L. et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665
• 2 Bisgaard M, Fenger K, Bulow S. et al. Familial adenomatous polyposis (FAP): frequency, penetrance and mutation rate. Hum Mutat 1994; 3: 121-125
• 3 Arvanitis M, Jagelman D. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639-642
• 4 Nugent KP, Spigelman AD, Phillips RKS. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993; 36: 1059-1062
• 5 Ghorbanoghli Z, Bastiaansen BAJ, Langers AMJ. et al. Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis. J Med Genet 2018; 55: 11-14
• 6 Walton S-J, Frayling IM, Clark SK. et al. Gastric tumours in FAP. Fam Cancer 2017; 16: 363-369
• 7 Leone P, Mankaney G, Sarvapelli S. et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc 2019; 89: 961-968
• 8 Mankaney G, Leone P, Cruise M. et al. Gastric cancer in FAP: a concerning rise in incidence. Fam Cancer 2017; 16: 371-376
• 9 Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988; 1: 1149-1151
• 10 Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 1993; 217: 101-108
• 11 Shibata C, Ogawa H, Miura K. et al. Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis. Tohoku J Exp Med 2013; 229: 143-146
• 12 Park SY, Ryu JK, Park JH. et al. Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in Korean patients with familial adenomatous polyposis. Gut Liver 2011; 5: 46-51
• 13 Wood LD, Salaria SN, Cruise MW. et al. Upper GI tract lesions in familial adnomatous polyposis (FAP). Am J Surg Pathol 2014; 38: 389-392
• 14 Church JM, McGannon E, Hull-Boiner S. et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35: 1170-1173
• 15 Sarre RG, Frost AG, Jagelman DG. et al. Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps. Gut 1987; 28: 306-314
• 16 Jagelman DG, Decosse JJ, Bussey HJR. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988; 331: 1149-1151
• 17 Lida M, Yao T, Itoh H. et al. Natural history of gastric adenomas in patients with familial adenomatosis coli (Gardner’s syndrome). Cancer 1988; 61: 605-611
• 18 Ngamruengphong S, Boardman L, Heigh H. et al. Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course. Hered Cancer Clin Pract 2014; 12: 4
• 19 Bianchi LK, Burke CA, Bennett AE. et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008; 6: 180-185
• 20 Spigelman A, Granowska M, Phillips R. Duodeno-gastric reflux and gastric adenomas: a scintigraphic study in patients with familial adenomatous polyposis. J R Soc Med 1991; 84: 476-478
• 21 Nakamura S, Matsumoto T, Kobori Y. et al. Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut 2002; 51: 485-489
• 22 Yamaguchi T, Ishida H, Ueno H. et al. Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Jpn J Clin Oncol 2016; 46: 310-315